NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
External Expert Profile
Adam Hutchings
Latest Publications
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
How is Quality of Life Measured for Health Technology Assessments?
Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?
Read more
© freshidea
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy
The Impact of New Medicines in the NHS: 70 Years of Innovation
